The Knops blood group system: A review

Immunohematology

Volumn 26, Issue 1, 2010, Pages 2-7

  Moulds, Joann M ^a  

^a LifeShare Blood Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN ANTIBODY; KNOPS ANTIGEN; KNOPS PROTEIN; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C3B RECEPTOR; CR1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ALLELE; BLOOD GROUP SYSTEM; CHROMOSOME 1; CYTOTOXICITY TEST; DISEASE ASSOCIATION; ETHNIC GROUP; GENETIC ANALYSIS; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; BLOOD; CHEMISTRY; CLASSIFICATION; COOMBS TEST; GENE DELETION; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; LEISHMANIASIS; MALARIA FALCIPARUM; MYCOBACTERIOSIS; ROSETTE FORMATION; SALIVA; URINE;

BLOOD GROUP ANTIGENS; CHROMOSOMES, HUMAN, PAIR 1; COOMBS' TEST; ETHNIC GROUPS; HUMANS; ISOANTIBODIES; LEISHMANIASIS; MALARIA, FALCIPARUM; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM INFECTIONS; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT 3B; ROSETTE FORMATION; SALIVA; SEQUENCE DELETION; URINE; COOMBS TEST;

EID: 77956574961     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Daniels GL, Anstee DJ, Cartron JP, et al. Blood group terminology 1995. Vox Sang 1995;69:265-79.
2. a, which reacts with 98% of red cell samples. Vox Sang 1965;10:405-15.
3. a (Cost). Vox Sang 1975;29:145-53.
4. a), a high frequency erythrocyte antigen. Transfusion 1970;10:737-8.
5. a (abstract). Transfusion 1980;20:630.
6. a (Knops). Transfusion 1978;18:566-8.
7. a; and its hypothetical allele. (abstract).Transfusion 1980;20:632.
8. d. Med Lab Sci 1983;40:113-21.
9. Daniels GL, Cartron JP, Fletcher A, et al. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver report. Vox Sang 2003;84:244-7.
10. Moulds JM, Pierce S, Peck KB, Tulley ML, Doumbo O, Moulds JJ. KAM: a new allele in the Knops Blood Group System (abstract). Transfusion 2005;45(Suppl):27A.
11. Daniels G, Castilho L, Flegel WA. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Cape Town report. Vox Sang 2007;92:250-3.
12. Covas DT, de Oliveira FS, Rodrigues ES, Abe-Sandes K, Silva WA Jr, Fontes AM. Knops blood group haplotypes among distinct Brazilian populations. Transfusion 2007;47:147-53.
13. Molthan L. The serology of the York-Cost-McCoy-Knops red blood cell system. Am J Med Technol 1983;49:49-56.
14. Moulds JM, Kassambara L, Middleton JJ. Identification of complement receptor one (CR1) polymorphisms in west Africa. Genes Immun 2000;1:325-9.
15. Moulds JM, Nickells MW, Moulds JJ, Brown M, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991;173:1159-63.
16. Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3501-7.
17. Petty AC, Green CA, Poole J, Daniels GL. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfus Med 1997;7:55-62.
18. Moulds MK. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies. Am J Med Technol 1981;10:789-95.
19. Reid ME, Lomas-Francis C. Knops blood group system. In: The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004:439-54.
20. Holme E, Fyfe A, Zoma A, Veitch J, Hunter J, Whaley K. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1986;63:41-8.
21. Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397-404.
22. Daniels GL, Shaw MA, Lomas CG, Leak MR, Tippett P. The effect of In(Lu) on some high-frequency antigens. Transfusion 1986;26:171-2.
23. Race RR, Sanger R. Some very frequent antigens. In: Blood groups in man. 6th ed. Oxford: Blackwell Scientific Publications, 1975:410-30.
24. Pascual M, Steiger G, Sadallah S, et al. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994;179:889-99.
25. Yoon SH, Fearon DT. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol 1985;134:3332-8.
26. Danielsson C, Pascual M, Larsen B, Steiger G, Schifferli JA. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 1994;24:2725-31.
27. Pascual M, Duchosal MA, Steiger G, et al. Circulating soluble CR1 (CD35). J Immunol 1993;151:1702-11.
28. Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996;36:517-20.
29. Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97:2879-85.
30. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273-81.
31. Vik DP, Wong WW. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J Immunol 1993;151:6214-24.
32. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986;164:50-9.
33. Cornillet P, Philbert F, Kazatchkine MD, Cohen JHM. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J Immunol Methods 1991;136:193-7.
34. Moulds JM, Brai M, Cohen JHM, et al. Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998;15:291-4.
35. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998;87:176-83.
36. Rowe JA, Plowe CV, Diallo DA, et al. Erythrocyte complement receptor 1 expression level does not correlate with HindIII restriction fragment length polymorphism in ; implications for studies on malaria susceptibility. Genes Immun 2002;8:497-500.
37. Cockburn IA, Rowe JA. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3′ untranslated regions of the CR1 gene. Int J Immunogenet 2006;33:17-20.
38. Daniels GL, Anstee DJ, Cartron JP, et al. International Society of Blood Transfusion working party on terminology for red cell surface antigens. Vox Sang 2001;80:193-6.
39. a. Transfusion 2002;42:251-6.
40. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte protein and complement-receptor 1. Nature 1997;388:292-5.
41. Rowe JA, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995;63:2323-6.
42. Da Silva RP, Hall BF, Joiner KA, Sacks DL. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 1989;143:617-22.
43. Payne NR, Horwitz MA. Phagocytosis of legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 1987;166:1377-89.
44. Robledo S, Wozencraft A, Valencia AZ, Saravia N. Human monocyte infection by Leishmania (viannia) panamensis. J Immunol 1994;152:1265-75.
45. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990;144:2771-80.
46. Noumsi GT, Tounkara A, Diallo D, Moulds JM. Knops blood group polymorphism and protection from Mycobacterium tuberculosis (abstract). Transfusion 2006;46(Suppl):19A.